FDA Finds Violations At Pa. J&J Plant
Johnson & Johnson/ Merck Consumer Pharmaceuticals Co. received a Form 483 report from the FDA following the agency’s recent inspection of the Lancaster manufacturing facility, the company said Monday.
A Form 483 report details any problems found during an FDA inspection.
“JJ/MCP takes the issues raised by the agency seriously and is fully...
To view the full article, register now.